Cargando…

Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review

INTRODUCTION: The era of biologic therapies has provided new options for the treatment of chronic plaque psoriasis. However, safety concerns have led to intensive screening and monitoring of patients receiving anti-tumor necrosis factor alpha (anti-TNF-alpha) agents. METHODS: The authors describe th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solovan, Caius, Chiticariu, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2013
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108098/ https://www.ncbi.nlm.nih.gov/pubmed/25135824 http://dx.doi.org/10.1007/s40121-013-0003-9

Ejemplares similares

Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients
por: Solovan, Caius, et al.
Publicado: (2012)

Postoperative Pyoderma Gangrenosum in Association with Renal Cell Carcinoma and Chronic Lymphocytic Leukemia
por: Solovan, Caius, et al.
Publicado: (2013)

Psoriasis and tuberculosis binomial distribution?
por: Chiriac, Anca, et al.
Publicado: (2014)

Cutaneous factitia in elderly patients: alarm signal for psychiatric disorders
por: Chiriac, Anca, et al.
Publicado: (2014)

Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: Real-World Data from a Care Center in Romania
por: Lupea-Chilom, Doriana-Sorina, et al.
Publicado: (2023)

Mucosal melanomas in the elderly: challenging cases and review of the literature
por: Baderca, Flavia, et al.
Publicado: (2014)

Case series of psoriasis associated with tumor necrosis factor-α inhibitors in children with chronic recurrent multifocal osteomyelitis
por: Campbell, Julie Ann, et al.
Publicado: (2018)

No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
por: Banse, Christopher, et al.
Publicado: (2013)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)

From Benign Inflammatory Dermatosis to Cutaneous Lymphoma. DNA Copy Number Imbalances in Mycosis Fungoides versus Large Plaque Parapsoriasis
por: Gug, Georgiana, et al.
Publicado: (2021)

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia
por: Balato, Anna, et al.
Publicado: (2011)

Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
por: Ikediobi, Ogechi, et al.
Publicado: (2015)

Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
por: Masukawa, Ena, et al.
Publicado: (2021)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

Generalized Molluscum contagiosum in an HIV infected patient
por: Roşca, Ovidiu, et al.
Publicado: (2014)

Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy
por: Shaikha, Samya Abu, et al.
Publicado: (2012)

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
por: Pangilinan, Mary Catherine G., et al.
Publicado: (2020)

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series
por: Shabeeb, Nadine, et al.
Publicado: (2021)

First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
por: Bouazzi, Omaima El, et al.
Publicado: (2016)

Unusual foreign body in the sigmoid colon, chronic alcohol abuse, and Fournier gangrene: a case report
por: Schulz, Dietmar, et al.
Publicado: (2015)

Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review
por: Peng, Yizhou, et al.
Publicado: (2020)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
por: Pinter, Andreas, et al.
Publicado: (2018)

Femoral Head Necrosis Due to Brucella Infection in China: Case Series and Literature Review
por: Wang, Jie, et al.
Publicado: (2022)

Serum Levels of Tumor Necrosis Factor - alpha in Patients With Psoriasis
por: Ovcina-Kurtovic, Nermina, et al.
Publicado: (2022)

Basal cell carcinomas in elderly patients treated by cryotherapy
por: Chiriac, Anca, et al.
Publicado: (2013)

CNARA: reliability assessment for genomic copy number profiles
por: Ai, Ni, et al.
Publicado: (2016)

Paradoxical Reaction In The Form Of New Pulmonary Mass During Anti-Tuberculosis Treatment: A Case Series And Literature Review
por: Guo, Ting, et al.
Publicado: (2019)

Chronic Ulcer on the Tongue as a Manifestation of Histoplasmosis During Anti-tumor Necrosis Factor-Alpha (TNF-⍺) Inhibitor Therapy for Psoriasis
por: Harrison, Iris, et al.
Publicado: (2023)

Aortic Involvement in Disseminated Tuberculosis – Challenges Beyond the Diagnosis
por: Shi, Yunzhen, et al.
Publicado: (2022)

Predicting the future of anti-tumor necrosis factor therapy
por: Verweij, Cornelis L
Publicado: (2009)

Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
por: Kołt-Kamińska, Marta, et al.
Publicado: (2021)

Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
por: Yoo, In Kyung, et al.
Publicado: (2014)

Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series
por: Peera, Melissa, et al.
Publicado: (2021)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
por: Rutkowski, David, et al.
Publicado: (2019)

Different disease, same challenges: Social determinants of tuberculosis and COVID-19
por: Duarte, R., et al.
Publicado: (2021)

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
por: Desai, Seemal R., et al.
Publicado: (2023)

Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia
por: Navarra, Sandra V, et al.
Publicado: (2014)

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021)

Alopecia secondary to anti-tumor necrosis factor-alpha therapy()
por: Ribeiro, Lara Beatriz Prata, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tadonfvgp3oeh08tnhb03bkgta